Clinical Trial Tests New Combinations of Immunotherapy Drugs to Treat Osteosarcoma
Friday, May 6th, 2022
Medications bring months more of life to dog Jelly Bean
Oncology
Defying Some Long Odds
Tuesday, April 26th, 2022
Stalwart Chesapeake Bay Retriever thrives after second cancer diagnosis
Protecting the Hearts of Canine Cancer Patients
Monday, March 7th, 2022
Heart damage has emerged among the distressing side effects of certain chemotherapy drugs
Dr. Jennifer Mahoney Joins Cummings School Faculty
Tuesday, February 15th, 2022
Dr. Mahoney brings deep expertise in oncology to the classroom, clinics, research, and her patients at Foster Hospital
Dr. Heather Gardner Among First Researchers to Utilize Advanced Technologies New to Cummings School
Tuesday, December 7th, 2021
Dr. Gardner studies bone cancer in dogs to develop new treatment options
Study Buddies
Tuesday, May 11th, 2021
Professor Cheryl London spoke with AKC Family Dog about the benefits of companion animal clinical trials, including a current lymphoma trial at Foster Hospital
Researchers study dogs for clues about cancer treatment side effects
Monday, February 15th, 2021
Research assistant professor Vicky Yang talks to WCVB Boston about work with Tufts Medical Center to study cancer treatment side effects in dogs and people
Investigating Cancer Treatments’ Cardiovascular Effects
Monday, December 14th, 2020
Tufts’ human and veterinary medical researchers collaborate to prevent and better treat cardiovascular damage in people and pets who have survived cancer
Improving the Odds of Surviving Lymphoma
Monday, October 26th, 2020
A clinical trial looks at whether combining immunotherapy with low doses of chemotherapy can improve outcomes and quality of life for dogs—and someday people.
Heartbreak for dog owners: Popular breed more prone now to cancer
Wednesday, February 19th, 2020
Cummings School’s Cheryl London is featured prominently in this Boston 25 News story on why golden retrievers are more susceptible to developing cancers than other dog breeds.